Marion Wobser

22PUBLICATIONS

106CO-AUTHORS

AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|May 22, 2026

Second-line treatment with tafasitamab and lenalidomide for relapsed/refractory primary cutaneous diffuse large B-cell lymphoma.

|Apr 23, 2026

DNA methylation-based classification of hematolymphoid neoplasms.

|Feb 11, 2026

Management of Mycosis Fungoides With Chlormethine Hydrochloride Gel in Combination With Systemic Therapies: A Case Series.

Gabor Dobos, Constanze Jonak, Kai-Christian Klespe

|Jan 10, 2026

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Christoph Blazejak, Mathias Oymanns, René Stranzenbach

|Dec 23, 2025

Haematopoietic stem cell transplantation for cutaneous T-cell lymphomas: Decision-guiding prognostic determinants yet to be clarified.

Marion Wobser

|Sep 30, 2025

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.

Patrick Schummer, Caroline Glatzel, Philipp Schrüfer

Pageof 4

Frequent Collaborators

Rudolf Stadler

Matthias Goebeler

Ulrike Wehkamp

Emmanuella Guenova

Susanne Melchers

Christina Mitteldorf

Katja Maurus

Jan P Nicolay

Julia Scarisbruck

Andreas Rosenwald

Frequent Collaborators

Rudolf Stadler

Matthias Goebeler

Ulrike Wehkamp

Emmanuella Guenova